Daniel Rauch

4.9k citations
63 papers · 3.9k · 2 hit papers · h-index 25

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Treatment and Pharmacology 7
    • Colorectal Cancer Treatments and Studies 3
    • Bone health and treatments 2
    • Lung Cancer Treatments and Mutations 9
    • Lung Cancer Diagnosis and Treatment 3

Daniel Rauch

61 papers receiving 3.8k citations

Daniel Rauch's Hit Papers

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study 2018 · 1.4k citations
1.4k0+3+7Years since publication4008001.2k

Peers

Daniel Rauch
Comparison fields: 5 of 88
  • Otorhinolaryngology 746
  • Oncology 1.6k
  • Cancer Research 368
  • Pulmonary and Respiratory Medicine 720
  • Pathology and Forensic Medicine 207
Replace Haythem Y. Ali with:
Haythem Y. Ali United States
Ioannis Boukovinas Greece
Jared M. Weiss United States
Ana Paula Victorino Brazil
Jared Weiss United States
Niels Hilmer Nielsen Sweden
Lucas Vieira dos Santos Brazil
Joshua Michael Bauml United States
Nong Xu China
Joo Hang Kim South Korea
Daniel Rauch relative to Haythem Y. Ali United States Haythem Y. Ali's profile →
Citations per field
00.5×2×2.5×
Haythem Y. Ali · 1×
Citations per year

Countries citing papers authored by Daniel Rauch

Since Specialization
Citations

This map shows the geographic impact of Daniel Rauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rauch more than expected).

Fields of papers citing papers by Daniel Rauch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rauch. The network helps show where Daniel Rauch may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Rauch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Rauch Line = papers co-authored together Daniel Rauch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Hit paper breakdown →
20181385
2 2017469
3
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Hit paper breakdown →
2015299
4 2017168
5 2016112
6 2008111
7 200592
8 201192
9 201991
10 201787
11 201268
12 201666
13 201551
14 201949
15 201744
16 201643
17 201938
18 200736
19 201634
20 201930

About Daniel Rauch

Daniel Rauch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Pathology and Forensic Medicine and Cancer Research, having authored 63 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Head and Neck Cancer Studies (7 papers), Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (7 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Otorhinolaryngology (746 citations), Oncology (1.6k citations), Cancer Research (368 citations), Pulmonary and Respiratory Medicine (720 citations) and Pathology and Forensic Medicine (207 citations). Daniel Rauch has collaborated with scholars based in Switzerland, Italy and Sweden. Frequent co-authors include Markus Borner, Dieter Koeberle, Piercarlo Saletti, A. Roth, Walter B. Mingrone, Roger von Moos, Peter Brauchli, Miklos Pless, Doris Lanz and Thomas Ruhstaller. Their work appears in journals such as Annals of Oncology, Blood, Oncology, BMC Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact